Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. - Wikidata - wikimedia - TriplyDB

Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.

Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.

http://www.wikidata.org/entity/Q44805674

about

Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.Collaboration with pharmacy services in a family practice for the medically underserved.Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital.Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic Structured group-based education for type 2 diabetes in primary care.Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus A review of pharmacist contributions to diabetes care in the United States.A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management.Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome.Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes.Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.Pharmacist-physician collaboration for diabetes care: the diabetes initiative program.Collaborative services among community pharmacies for patients with diabetes.Development of an Ambulatory Clinical Pharmacy Prioritization Prediction Model for Patients With Diabetes.An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention.

P2860

Q28192612-E97853AB-8F40-46CB-96C8-E1AC99AB013B Q33967473-B06473DD-C056-4B95-BE2B-2318181FAE02 Q34053181-1E335138-C7A8-46EC-A47E-95D6787092B2 Q35152604-A21B3F0F-A6E1-4992-9C5D-04F12D041510 Q35657253-DAB2725C-6320-4270-9EB4-5668C96927E8 Q36285747-B5F6661C-A9F8-41EB-87CA-258F6290991C Q36823564-6DEF1E3E-E66C-4F35-93B0-D9FB43BB31B6 Q36915765-30A66053-263F-473E-8A0E-873801AEEE5D Q37201693-00080E18-03C8-490F-9BBE-9E112B00CB40 Q37867283-34303FEF-EC5B-4927-B1E6-449D23B80675 Q38185301-268B4370-DB8B-4423-8C8E-B264E801EFEC Q40394919-BF8EF316-DF04-414A-BDD9-1563C1EB5EAF Q40402216-C0F48627-BF8A-41A7-A44B-713C84E1C288 Q44932292-CC70C0C0-09FF-49BB-ADB0-34BD07F599C2 Q45330171-3F3A1087-309B-4833-893C-AA904851348F Q46611031-FF0E22CF-1D47-4FE3-B145-C1BC091FB527 Q46689348-90C13B45-26C2-411F-9641-3BBDB68C1235 Q47396141-210A4A95-C910-4B4B-871F-64EE26CA47BC Q48849892-4475670E-CA43-4B4C-BA98-6B1E3A6CB3F3

P2860

Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.

http://www.wikidata.org/entity/Q44805674

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@en

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@nl

type

label

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@en

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@nl

prefLabel

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@en

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@nl

P1433

Q44805674-644A5DD1-1509-4843-9DAD-39E7691EB54A

P1476

Q44805674-B05708B5-8568-44B3-887B-71C5A5A2314C

P2093

Q44805674-7271DA1C-F501-4F19-B29F-C22A3C66882F

Q44805674-8FD34BA4-660B-4FEA-B25E-7CFFDBDB0C74

Q44805674-A18F3F27-E1B8-4AC7-99DB-BAEB72EC15D3

Q44805674-AABCEE2D-8CF3-4C83-AC65-C4D80AAF1865

Q44805674-D89F0D6B-B39E-415E-9DC3-7418AA37A455

P2860

Q44805674-0554020A-7AB7-4925-AF98-48435BFC416B

Q44805674-17874BEA-D9F8-4211-B08C-789A86E21682

Q44805674-2131D19D-525B-49F8-84D5-5D2B02009652

Q44805674-2C5AC6F0-ED04-4AEB-B79C-A3E8C8633D08

Q44805674-40580AA0-5444-40FE-8E18-3E067AF12F1F

Q44805674-4EDC10C9-B5DA-469D-B099-C2B4E81E3273

Q44805674-7E036E9B-C375-4CED-9006-729990A2075B

Q44805674-B5C14DD8-9154-40C1-B476-6B4EA0F45CD0

Q44805674-C164BD75-A18B-4F1E-91D5-8150D4BAEC21

Q44805674-EC04E2C6-7266-4B4A-B3A1-B80B90C6F5CC

P304

Q44805674-19A255F5-AFF3-4289-9547-8F19E5F10269

P31

Q44805674-C240C46C-7738-4FB1-9467-C4AEB433A3A5

P356

Q44805674-1508C5A2-2D29-4F0C-B428-15ECBE6FFC23

P407

Q44805674-F81D4221-6106-4592-9216-AE49231A47A9

P433

Q44805674-CBB9DF5F-14D4-4623-9177-DBC27C07CAD4

P478

Q44805674-E6FFEB64-12EE-4C42-8F0D-BF1A14E7FA84

P577

Q44805674-5EEE5EE1-AF18-4B4B-851C-2C06D826C688

P698

Q44805674-B9A2A2B7-8451-44C0-946D-3C9698EF5FB1

P921

Q44805674-630B1B31-5AB5-4E3C-B4E8-6BFE46440BA7

Q44805674-F2A45F23-E313-4E91-8900-3519D22338CC

P356

P1433

Annals of Pharmacotherapy

P1476

Glycosylated hemoglobin, cardi ...... n a pharmacist-managed clinic.

@en

P2093

James S Kalus

http://www.w3.org/2001/XMLSchema#string

Michael F Caron

http://www.w3.org/2001/XMLSchema#string

Patricia Hill

http://www.w3.org/2001/XMLSchema#string

Seth T Cioffi

http://www.w3.org/2001/XMLSchema#string

Thomas E Buckley

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

The UKPDS: implications for the dyslipidaemic patient.

Effect of a pharmacist-managed diabetes care program in a free medical clinic.

A diabetes report card for the United States: quality of care in the 1990s.

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.

Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.

Management of patients with type 2 diabetes by pharmacists in primary care clinics.

Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.

P304

771-775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1D359

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15031417

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio